Breakthru Medicine

Breakthru Medicine focuses on aggressive solid tumors with the highest unmet need—cancers where patients have exhausted existing options.

Health and bio

Latest funding

$60M Series A · February 5, 2026

Source: AllSci

Funding history ↓

Website: breakthrumed.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Oncology, Pharmaceutical, Therapeutics.

Stage: Series A.

Based in: Phoenix, United States.

Founded: 2025.

Last round: Feb 5, 2026 · 280 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredOct 23, 2025 (13 months old)

About Breakthru Medicine

By attacking the specific molecular drivers of each tumor, we design precision therapies for patients whose cancers have become resistant to current treatments.

Funding rounds

February 5, 2026
Series A · $60M
DDave Morehead, FFred Eshelman, MMark Gergen
Source: AllSci
October 23, 2025
Website created

Founders and team

BB
Brian Barnett Founder

LinkedIn
MM
Mark Mulvihill Founder

LinkedIn
SP
Steve Potts Founder

@stevenjpotts · LinkedIn

Investors

Companies like Breakthru Medicine

AA2 Biotherapeutics$80M Series B+ · Jan 2025
OOna Therapeutics$86.6M Series B+ · Oct 2026
HHaptena Therapeutics$3.53M Seed · Dec 2025
CCatalYm$150M Series B+ · Jul 2024
RRondo Therapeutics$67M Series A · Mar 2022
AArsenal BiosciencesSeries B+ · Oct 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/breakthru-medicine (get a free API key).